Literature DB >> 23678004

Parp-2 is required to maintain hematopoiesis following sublethal γ-irradiation in mice.

Jordi Farrés1, Juan Martín-Caballero, Carlos Martínez, Juan J Lozano, Laura Llacuna, Coral Ampurdanés, Cristina Ruiz-Herguido, Françoise Dantzer, Valérie Schreiber, Andreas Villunger, Anna Bigas, José Yélamos.   

Abstract

Hematopoietic stem cells self-renew for life to guarantee the continuous supply of all blood cell lineages. Here we show that Poly(ADP-ribose) polymerase-2 (Parp-2) plays an essential role in hematopoietic stem/progenitor cells (HSPC) survival under steady-state conditions and in response to stress. Increased levels of cell death were observed in HSPC from untreated Parp-2-/- mice, but this deficit was compensated by increased rates of self-renewal, associated with impaired reconstitution of hematopoiesis upon serial bone marrow transplantation. Cell death after γ-irradiation correlated with an impaired capacity to repair DNA damage in the absence of Parp-2. Upon exposure to sublethal doses of γ-irradiation, Parp-2-/- mice exhibited bone marrow failure that correlated with reduced long-term repopulation potential of irradiated Parp-2-/- HSPC under competitive conditions. In line with a protective role of Parp-2 against irradiation-induced apoptosis, loss of p53 or the pro-apoptotic BH3-only protein Puma restored survival of irradiated Parp-2-/- mice, whereas loss of Noxa had no such effect. Our results show that Parp-2 plays essential roles in the surveillance of genome integrity of HSPC by orchestrating DNA repair and restraining p53-induced and Puma-mediated apoptosis. The data may affect the design of drugs targeting Parp proteins and the improvement of radiotherapy-based therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23678004      PMCID: PMC4918799          DOI: 10.1182/blood-2012-12-472845

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  42 in total

1.  PARP-2 deficiency affects the survival of CD4+CD8+ double-positive thymocytes.

Authors:  José Yélamos; Yolanda Monreal; Luis Saenz; Enrique Aguado; Valérie Schreiber; Rubén Mota; Teodomiro Fuente; Alfredo Minguela; Pascual Parrilla; Gilbert de Murcia; Elena Almarza; Pedro Aparicio; Josiane Ménissier-de Murcia
Journal:  EMBO J       Date:  2006-08-31       Impact factor: 11.598

Review 2.  Repopulation of cancer cells during therapy: an important cause of treatment failure.

Authors:  John J Kim; Ian F Tannock
Journal:  Nat Rev Cancer       Date:  2005-07       Impact factor: 60.716

3.  Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells.

Authors:  Keisuke Ito; Atsushi Hirao; Fumio Arai; Sahoko Matsuoka; Keiyo Takubo; Isao Hamaguchi; Kana Nomiyama; Kentaro Hosokawa; Kazuhiro Sakurada; Naomi Nakagata; Yasuo Ikeda; Tak W Mak; Toshio Suda
Journal:  Nature       Date:  2004-10-21       Impact factor: 49.962

4.  p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa.

Authors:  Andreas Villunger; Ewa M Michalak; Leigh Coultas; Franziska Müllauer; Gunther Böck; Michael J Ausserlechner; Jerry M Adams; Andreas Strasser
Journal:  Science       Date:  2003-09-18       Impact factor: 47.728

Review 5.  Regulation of hematopoietic stem cell growth.

Authors:  E C Attar; D T Scadden
Journal:  Leukemia       Date:  2004-11       Impact factor: 11.528

Review 6.  DNA repair is crucial for maintaining hematopoietic stem cell function.

Authors:  Laura J Niedernhofer
Journal:  DNA Repair (Amst)       Date:  2008-01-08

7.  Histone deacetylase inhibitors sensitize prostate cancer cells to agents that produce DNA double-strand breaks by targeting Ku70 acetylation.

Authors:  Chang-Shi Chen; Yu-Chieh Wang; Hsiao-Ching Yang; Po-Hsien Huang; Samuel K Kulp; Chih-Cheng Yang; Yen-Shen Lu; Shigemi Matsuyama; Ching-Yu Chen; Ching-Shih Chen
Journal:  Cancer Res       Date:  2007-06-01       Impact factor: 12.701

8.  Global analysis of proliferation and cell cycle gene expression in the regulation of hematopoietic stem and progenitor cell fates.

Authors:  Emmanuelle Passegué; Amy J Wagers; Sylvie Giuriato; Wade C Anderson; Irving L Weissman
Journal:  J Exp Med       Date:  2005-12-05       Impact factor: 14.307

9.  Hematopoiesis: an evolving paradigm for stem cell biology.

Authors:  Stuart H Orkin; Leonard I Zon
Journal:  Cell       Date:  2008-02-22       Impact factor: 41.582

10.  DNA repair is limiting for haematopoietic stem cells during ageing.

Authors:  Anastasia Nijnik; Lisa Woodbine; Caterina Marchetti; Sara Dawson; Teresa Lambe; Cong Liu; Neil P Rodrigues; Tanya L Crockford; Erik Cabuy; Alessandro Vindigni; Tariq Enver; John I Bell; Predrag Slijepcevic; Christopher C Goodnow; Penelope A Jeggo; Richard J Cornall
Journal:  Nature       Date:  2007-06-07       Impact factor: 49.962

View more
  23 in total

1.  Coordinated signals from PARP-1 and PARP-2 are required to establish a proper T cell immune response to breast tumors in mice.

Authors:  Lucia Moreno-Lama; Miguel A Galindo-Campos; Carlos Martínez; Laura Comerma; Ivonne Vazquez; María Vernet-Tomas; Coral Ampurdanés; Nura Lutfi; Juan Martin-Caballero; Françoise Dantzer; Miguel Quintela-Fandino; Syed O Ali; Jaime Jimeno; José Yélamos
Journal:  Oncogene       Date:  2020-01-30       Impact factor: 9.867

2.  Talazoparib in Patients with a Germline BRCA-Mutated Advanced Breast Cancer: Detailed Safety Analyses from the Phase III EMBRACA Trial.

Authors:  Sara A Hurvitz; Anthony Gonçalves; Hope S Rugo; Kyung-Hun Lee; Louis Fehrenbacher; Lida A Mina; Sami Diab; Joanne L Blum; Jayeta Chakrabarti; Mohamed Elmeliegy; Liza DeAnnuntis; Eric Gauthier; Akos Czibere; Iulia Cristina Tudor; Ruben G W Quek; Jennifer K Litton; Johannes Ettl
Journal:  Oncologist       Date:  2019-11-25

Review 3.  Understanding specific functions of PARP-2: new lessons for cancer therapy.

Authors:  Syed O Ali; Farhaan A Khan; Miguel A Galindo-Campos; José Yélamos
Journal:  Am J Cancer Res       Date:  2016-09-01       Impact factor: 6.166

4.  Coordinated signals from the DNA repair enzymes PARP-1 and PARP-2 promotes B-cell development and function.

Authors:  Ludovic Deriano; José Yélamos; Miguel A Galindo-Campos; Marie Bedora-Faure; Jordi Farrés; Chloé Lescale; Lucia Moreno-Lama; Carlos Martínez; Juan Martín-Caballero; Coral Ampurdanés; Pedro Aparicio; Françoise Dantzer; Andrea Cerutti
Journal:  Cell Death Differ       Date:  2019-04-17       Impact factor: 15.828

5.  Low doses of oxygen ion irradiation cause long-term damage to bone marrow hematopoietic progenitor and stem cells in mice.

Authors:  Yingying Wang; Jianhui Chang; Xin Li; Rupak Pathak; Vijayalakshmi Sridharan; Tamako Jones; Xiao Wen Mao; Gregory Nelson; Marjan Boerma; Martin Hauer-Jensen; Daohong Zhou; Lijian Shao
Journal:  PLoS One       Date:  2017-12-12       Impact factor: 3.240

6.  PARP-1/PARP-2 double deficiency in mouse T cells results in faulty immune responses and T lymphomas.

Authors:  Judith Navarro; Beatriz Gozalbo-López; Andrea C Méndez; Françoise Dantzer; Valérie Schreiber; Carlos Martínez; David M Arana; Jordi Farrés; Beatriz Revilla-Nuin; María F Bueno; Coral Ampurdanés; Miguel A Galindo-Campos; Philip A Knobel; Sandra Segura-Bayona; Juan Martin-Caballero; Travis H Stracker; Pedro Aparicio; Margarita Del Val; José Yélamos
Journal:  Sci Rep       Date:  2017-02-09       Impact factor: 4.379

7.  PARP1 and PARP2 stabilise replication forks at base excision repair intermediates through Fbh1-dependent Rad51 regulation.

Authors:  George E Ronson; Ann Liza Piberger; Martin R Higgs; Anna L Olsen; Grant S Stewart; Peter J McHugh; Eva Petermann; Nicholas D Lakin
Journal:  Nat Commun       Date:  2018-02-21       Impact factor: 14.919

8.  PARP-2 sustains erythropoiesis in mice by limiting replicative stress in erythroid progenitors.

Authors:  J Farrés; L Llacuna; J Martin-Caballero; C Martínez; J J Lozano; C Ampurdanés; A J López-Contreras; L Florensa; J Navarro; E Ottina; F Dantzer; V Schreiber; A Villunger; O Fernández-Capetillo; J Yélamos
Journal:  Cell Death Differ       Date:  2014-12-12       Impact factor: 15.828

Review 9.  Development of the PARP inhibitor talazoparib for the treatment of advanced BRCA1 and BRCA2 mutated breast cancer.

Authors:  Evthokia A Hobbs; Jennifer K Litton; Timothy A Yap
Journal:  Expert Opin Pharmacother       Date:  2021-07-26       Impact factor: 4.103

10.  Molecular evolutionary patterns of NAD+/Sirtuin aging signaling pathway across taxa.

Authors:  Uma Gaur; Jianbo Tu; Diyan Li; Yue Gao; Ting Lian; Boyuan Sun; Deying Yang; Xiaolan Fan; Mingyao Yang
Journal:  PLoS One       Date:  2017-08-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.